Sight Sciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SGHT research report →
About the company
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients.
- CEO
- Paul Badawi
- IPO
- 2021
- Employees
- 216
- HQ
- Menlo Park, CA, US
Price Chart
- Market Cap
- $296.53M
- P/E
- -7.69
- P/S
- 3.73
- P/B
- 5.45
- EV/EBITDA
- -8.00
- Div Yield
- 0.00%
- Gross Margin
- 86.17%
- Op Margin
- -44.82%
- Net Margin
- -46.83%
- ROE
- -59.10%
- ROIC
- -37.24%
- Revenue
- $77.36M · -3.13%
- Net Income
- $-38,426,000 · 25.40%
- EPS
- $-0.74 · 28.16%
- Op Income
- $-37,099,000
- FCF YoY
- -31.59%
- 52W High
- $9.24
- 52W Low
- $3.11
- 50D MA
- $4.87
- 200D MA
- $5.36
- Beta
- 2.40
- Avg Volume
- 241.25K
Get TickerSpark's AI analysis on SGHT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 26 | Encrantz Staffan | buy | 14,100 |
| Jun 4, 26 | Fountain Tamara | other | 28,261 |
| Jun 4, 26 | Encrantz Staffan | other | 28,261 |
| Jun 4, 26 | Burbach Gerhard F | other | 28,261 |
| Jun 4, 26 | Zurbay Donald | other | 28,261 |
| Jun 4, 26 | Mazzacco Catherine | other | 28,261 |
| May 18, 26 | Bauerlein Alison | sell | 12,728 |
| Apr 6, 26 | Rodberg James | sell | 7,231 |
| Apr 6, 26 | HAYDEN JEREMY B. | sell | 13,761 |
| Apr 2, 26 | Bauerlein Alison | sell | 25,874 |
Our SGHT coverage
Recent articles, reports, and earnings notes.
No research on SGHT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SGHT report →Similar companies
Peers in the same neighborhood.